Date	Period	Revenue/Estimate	Earnings Call
Apr 30, 2025	2025/Q1	-- / 52.069B	--
Mar 31, 2025	2024/Q4	-- / 142.588B	--
Oct 30, 2024	2024/Q3	77.116B / --	--
Aug 31, 2024	2024/Q2	81.185B / 87.645B	--
Apr 29, 2024	2024/Q1	61.594B / 60.271B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 30, 20252025/Q1-- / 52.069B--

Mar 31, 20252024/Q4-- / 142.588B--

Oct 30, 20242024/Q377.116B / ----

Aug 31, 20242024/Q281.185B / 87.645B--

Apr 29, 20242024/Q161.594B / 60.271B--

Unlock Free Earnings Estimates

Open Account

China Vanke Co.,Ltd. Earnings Reports

Vanke A: 2024 Annual Report

12:00 ET

Vanke A: 2024 Annual Report Summary

12:00 ET

Vanke A: 2024 Annual Results Forecast

Jan 27 03:28 ET

Vanke A: Briefing on sales and recent new projects in December 2024

Jan 3 11:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Zhejiang Huaye Plastics Machinery

Glory View Technology

301396

94.81 +20.00%

Guangzhou Sie Consulting

300687

32.65 +19.99%

Tibet Duo Rui Pharmaceutical

301075

25.33 +19.99%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Mar 31, 2025

Buy

Strong Buy
50.00%
Buy
35.00%
Hold
15.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

AH Stocks

Intraday+0.32%

Securities and Fund Holdings

Intraday+0.03%

Super Brands

Intraday-0.38%